These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30630883)

  • 41. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy.
    Varela Cagetti L; Zemmour C; Minsat M; Lambaudie E; Houvenaeghel G; Provansal M; Cappiello MA; Rua S; Jauffret C; Ferré M; Mailleux H; Gonzague L; Tallet A
    Gynecol Oncol; 2020 Feb; 156(2):328-334. PubMed ID: 31864683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience.
    Huertas A; Dumas I; Escande A; Rivin Del Campo E; Felefly T; Canova CH; Tailleur A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2018; 17(3):571-579. PubMed ID: 29426746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer.
    Dang YZ; Li P; Li JP; Bai F; Zhang Y; Mu YF; Li WW; Wei LC; Shi M
    J Cancer; 2018; 9(9):1635-1641. PubMed ID: 29760802
    [No Abstract]   [Full Text] [Related]  

  • 49. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
    Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
    Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
    Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies.
    Fokdal L; Tanderup K; Pötter R; Sturdza A; Kirchheiner K; Chargari C; Jürgenliemk-Schulz IM; Segedin B; Tan LT; Hoskin P; Mahantshetty U; Bruheim K; Rai B; Kirisits C; Lindegaard JC;
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):887-894. PubMed ID: 30419309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical audit of dose-escalated radical radiotherapy for advanced cervical carcinoma using a pragmatic protocol (3 fractions of 8 Gy HDR brachytherapy).
    Goswami J; Manir KS; Mondal M; Mallik S; Das S; Sen A; Pal B; Das S; Palit S; Sarkar P
    Gynecol Oncol Rep; 2021 Aug; 37():100822. PubMed ID: 34258362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?
    Mazeron R; Gouy S; Escande A; Dumas I; Rivin Del Campo E; Bentivegna E; Bacorro W; Lefkopoulos D; Deutsch E; Morice P; Haie-Meder C; Chargari C
    Brachytherapy; 2017; 16(4):862-869. PubMed ID: 28551312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined external pelvic chemoradiotherapy and image-guided adaptive brachytherapy in treatment of advanced cervical carcinoma: experience from a single institution.
    Möller S; Mordhorst LB; Hermansson RS; Karlsson L; Granlund U; Riemarsma C; Sorbe B
    J Contemp Brachytherapy; 2020 Aug; 12(4):356-366. PubMed ID: 33293975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiochemotherapy for patients with locally advanced cervical cancer: early results.
    Ozsaran Z; Yalman D; Yürüt V; Aras A; Ozsaran A; Hanhan M; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(2):191-4. PubMed ID: 12701977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.